Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results. [electronic resource]
Producer: 20140908Description: 16-34 p. digitalISSN:- 1941-9260
- Canagliflozin
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2 -- drug therapy
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Glucosides -- administration & dosage
- Humans
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- administration & dosage
- Incidence
- Kidney Function Tests
- Lipids -- blood
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Severity of Illness Index
- Sex Factors
- Sodium-Glucose Transporter 2 Inhibitors
- Thiophenes -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.